搜尋結果
Dosage/Direction for Use. IM 2 inj at 2-mth intervals (1 at the age of 2 mth & 1 at the age of 4 mth), followed by 1 booster inj at the age of 11 mth, then another booster inj at the age of 6 yr; booster vaccination for childn 11-13 yr who did not receive a vaccine containing the pertussis valence at normal conc at the age of 6 yr ...
Tetralysal (lymecycline): Treatment of Brucella infection; Pasteurella infection; pulmonary, genito-urinary & ophth infections due to Chlamydiae; pulmon.
Malarone (atovaquone + proguanil): Prophylaxis of P. falciparum malaria & treatment of acute, uncomplicated P. falciparum malaria.
Contents. Per tab Dihydrocodeine bitartrate 5 mg, guaifenesin 50 mg, DL-methylephedrine HCl 17.5 mg, chlorpheniramine maleate 1.5 mg. Per 100 mL syrup Dihydrocodeine bitartrate 50 mg, DL-methylephedrine HCl 131.25 mg, guaifenesin 375 mg, chlorpheniramine maleate 15 mg.
Indications/Uses. In combination w/ standard daunorubicin & cytarabine induction & high-dose cytarabine consolidation chemotherapy, & for patients in complete response followed by Rydapt single agent maintenance therapy, for adult patients w/ newly diagnosed acute myeloid leukaemia (AML) who are FLT3 mutation +ve.
Primary hypercholesterolaemia (heterozygous familial or nonfamilial) & mixed dyslipidaemia Adult Initial dose: 10 or 20 mg once daily; 40 mg daily in patients requiring >45% reductions in LDL-cholesterol. Maintenance dose: 10-80 mg once daily. Heterozygous familial hypercholesterolaemia Childn ≥10 yr 10 mg once daily. Max: 20 mg daily.
Indications/Uses. Symptomatic treatment of allergic rhino-conjunctivitis (seasonal & perennial) & urticaria. 20 mg tab For adult & adolescents ≥12 yr. 10 mg orodispersible tab (ODT) For childn 6-11 yr w/ body wt of at least 20 kg. Click to view Labixten detailed prescribing information.
